Carlsbad’s Ionis gets $25M upfront for licensing hepatitis B drugs to GSK August 27, 2019 sandiegobiotech News Comments Off on Carlsbad’s Ionis gets $25M upfront for licensing hepatitis B drugs to GSK Carlsbad's Ionis gets $25M upfront for licensing hepatitis B drugs to GSK Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds 00:00 / Subscribe Share RSS Feed Share Link Embed Hundreds of millions more possible to Ionis if drugs reach milestones